The RSI Oscillator for AORT moved out of oversold territory on October 12, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 20 similar instances when the indicator left oversold territory. In 18 of the 20 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on AORT as a result. In 62 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for AORT just turned positive on October 14, 2026. Looking at past instances where AORT's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
Following a +5.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in 220 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 62 cases where AORT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
AORT broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AORT entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.594) is normal, around the industry mean (4.170). AORT's P/E Ratio (-474.200) is considerably lower than the industry average of (1.500). Projected Growth (PEG Ratio) (4.200) is also within normal values, averaging (11.253). Dividend Yield (0.005) settles around the average of (0.010) among similar stocks. P/S Ratio (2.603) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. AORT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 95 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AORT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
UTMD saw its Momentum Indicator move below the 0 level on October 23, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned negative. In 64 of the 102 cases, the stock moved further down in the following days. The odds of a decline are at 63%.
The Moving Average Convergence Divergence Histogram (MACD) for UTMD turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 26 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 52%.
UTMD moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for UTMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UTMD's RSI Indicator exited the oversold zone, 12 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 48%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTMD advanced for three days, in 138 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
UTMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. UTMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.883) is normal, around the industry mean (4.946). P/E Ratio (22.079) is within average values for comparable stocks, (38.797). Projected Growth (PEG Ratio) (5.980) is also within normal values, averaging (4.143). UTMD has a moderately high Dividend Yield (0.017) as compared to the industry average of (0.005). P/S Ratio (6.549) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
AORT | UTMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 81 Overvalued | |
PROFIT vs RISK RATING 1..100 | 95 | 100 | |
SMR RATING 1..100 | 91 | 75 | |
PRICE GROWTH RATING 1..100 | 62 | 49 | |
P/E GROWTH RATING 1..100 | 99 | 16 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AORT's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for UTMD (81). This means that AORT’s stock grew significantly faster than UTMD’s over the last 12 months.
AORT's Profit vs Risk Rating (95) in the Medical Specialties industry is in the same range as UTMD (100). This means that AORT’s stock grew similarly to UTMD’s over the last 12 months.
UTMD's SMR Rating (75) in the Medical Specialties industry is in the same range as AORT (91). This means that UTMD’s stock grew similarly to AORT’s over the last 12 months.
UTMD's Price Growth Rating (49) in the Medical Specialties industry is in the same range as AORT (62). This means that UTMD’s stock grew similarly to AORT’s over the last 12 months.
UTMD's P/E Growth Rating (16) in the Medical Specialties industry is significantly better than the same rating for AORT (99). This means that UTMD’s stock grew significantly faster than AORT’s over the last 12 months.
| AORT | UTMD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 48% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 58% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 63% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 52% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 51% |
| TrendMonth ODDS (%) | 2 days ago 75% | 2 days ago 46% |
| Advances ODDS (%) | 2 days ago 73% | 3 days ago 56% |
| Declines ODDS (%) | 8 days ago 67% | 7 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 64% |
| Aroon ODDS (%) | 2 days ago 73% | N/A |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AORT’s FA Score shows that 1 FA rating(s) are green while UTMD’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AORT’s TA Score shows that 4 TA indicator(s) are bullish while UTMD’s TA Score has 4 bullish TA indicator(s).
AORT (@Medical/Nursing Services) experienced а +3.36% price change this week, while UTMD (@Pharmaceuticals: Other) price change was -4.16% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.37%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.02%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.45%. For the same industry, the average monthly price growth was +1.98%, and the average quarterly price growth was +15.93%.
AORT is expected to report earnings on Nov 05, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+3.45% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, AORT has been loosely correlated with VREX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then VREX could also see price increases.
| Ticker / NAME | Correlation To AORT | 1D Price Change % | ||
|---|---|---|---|---|
| AORT | 100% | +0.55% | ||
| VREX - AORT | 55% Loosely correlated | +0.38% | ||
| TCMD - AORT | 43% Loosely correlated | +8.35% | ||
| LMAT - AORT | 42% Loosely correlated | -0.81% | ||
| ISRG - AORT | 39% Loosely correlated | +0.89% | ||
| UTMD - AORT | 39% Loosely correlated | -0.75% | ||
More | ||||
A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.
| Ticker / NAME | Correlation To UTMD | 1D Price Change % | ||
|---|---|---|---|---|
| UTMD | 100% | -0.75% | ||
| CERS - UTMD | 50% Loosely correlated | -0.85% | ||
| TMCI - UTMD | 47% Loosely correlated | +0.23% | ||
| INMD - UTMD | 47% Loosely correlated | +2.77% | ||
| ITGR - UTMD | 44% Loosely correlated | N/A | ||
| IART - UTMD | 43% Loosely correlated | +0.15% | ||
More | ||||